GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » BioTelemetry Inc (NAS:BEAT) » Definitions » Price-to-Owner-Earnings

BioTelemetry (BioTelemetry) Price-to-Owner-Earnings : 64.83 (As of Apr. 29, 2024)


View and export this data going back to 2008. Start your Free Trial

What is BioTelemetry Price-to-Owner-Earnings?

As of today (2024-04-29), BioTelemetry's share price is $71.96. BioTelemetry's Owner Earnings per Share (TTM) ended in Sep. 2020 was $1.11. It's Price-to-Owner-Earnings for today is 64.83.


The historical rank and industry rank for BioTelemetry's Price-to-Owner-Earnings or its related term are showing as below:

BEAT' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 36.34   Med: 61.81   Max: 453.46
Current: 64.88

During the past 13 years, the highest Price-to-Owner-Earnings of BioTelemetry was 453.46. The lowest was 36.34. And the median was 61.81.


BEAT's Price-to-Owner-Earnings is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 25.575 vs BEAT: 64.88

As of today (2024-04-29), BioTelemetry's share price is $71.96. BioTelemetry's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was $0.47. Therefore, BioTelemetry's PE Ratio for today is 153.11.

As of today (2024-04-29), BioTelemetry's share price is $71.96. BioTelemetry's EPS without NRI for the trailing twelve months (TTM) ended in was $0.47. Therefore, BioTelemetry's PE Ratio without NRI for today is 153.11.

During the past 13 years, BioTelemetry's highest PE Ratio without NRI was 164.51. The lowest was 35.37. And the median was 63.15.


BioTelemetry Price-to-Owner-Earnings Historical Data

The historical data trend for BioTelemetry's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioTelemetry Price-to-Owner-Earnings Chart

BioTelemetry Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 55.74 - 76.37 122.81

BioTelemetry Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.87 122.81 261.97 44.13 40.95

Competitive Comparison of BioTelemetry's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, BioTelemetry's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioTelemetry's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BioTelemetry's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where BioTelemetry's Price-to-Owner-Earnings falls into.



BioTelemetry Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

BioTelemetry's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=71.96/1.11
=64.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioTelemetry  (NAS:BEAT) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


BioTelemetry Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of BioTelemetry's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


BioTelemetry (BioTelemetry) Business Description

Traded in Other Exchanges
N/A
Address
1000 Cedar Hollow Road, Suite 102, Malvern, PA, USA, 19355
BioTelemetry Inc provides monitoring services and digital population health management for healthcare providers, medical device manufacturing, and centralized core laboratory services for clinical research. It operates under healthcare, technology, and research segments. The Healthcare segment is focused on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders. The Research segment is engaged in central core laboratory services providing cardiac monitoring, imaging services, scientific consulting and data management services for drug and medical device trials and the Technology segment, focuses on the development, manufacturing, testing, and marketing of cardiovascular and blood glucose monitoring devices to medical companies, clinics and hospitals.
Executives
Kirk E Gorman director 367 SOUTH GULPH ROAD, KING PRUSSIA PA 19406
Stephen Rietiker director C/O BIOTELEMETRY, INC., 1000 CEDAR HOLLOW RD. SUITE 102, MALVERN PA 19355
Tiffany Olson director C/O CASTLE BIOSCIENCES, INC., 505 S. FRIENDSWOOD DRIVE, SUITE 401, FRIENDSWOOD TX 77546
Joseph A. Frick director ONE COMMERCE SQUARE 2005 MARKET ST., SUITE 3300 19103 PR 19073
Laura N. Dietch director 1000 CEDAR HOLLOW RD. SUITE 102 MALVERN PA 19355
Anthony James Conti director 76 GOLFVIEW DRIVE, IVYLAND PA 18974
Rebecca W Rimel director 345 PARK AVENUE, NEW YORK NY 10154
Robert J. Rubin director 7901 SPRINGER ROAD, BETHESDA MD 20817
Hill Colin director 196 BROADWAY CAMBRIDGE MA 02139
Andrei G Stoica officer: SVP & CTO 1000 CEDAR HOLLOW ROAD, MALVERN PA 19355
Joseph H Capper director, officer: President & CEO BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355
Manish Wadhwa officer: SVP & CMO 1000 CEDAR HOLLOW ROAD MALVERN PA 19355
Fred Broadway officer: President BioTel Heart BIOTELEMETRY, INC. 1000 CEDAR HOLLOW ROAD, #102 MALVERN PA 19355
Daniel Wisniewski officer: SVP, Technical Operations BIOTELEMETRY, INC. 1000 CEDAR HOLLOW ROAD, #102 MALVERN PA 19355
Heather C Getz officer: EVP, CFO & CAO BIOTELEMETRY, INC., 1000 CEDAR HOLLOW ROAD, #102, MALVERN PA 19355